Contineum Therapeutics, Inc. (CTNM) Operating margin
Contineum Therapeutics, Inc. (CTNM) operating margin by fiscal year — reported operating income divided by reported revenue.
32.2%FY2023
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | 32.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CTNM financial trends
CTNM RevenueCTNM Net incomeCTNM Net marginCTNM Gross profitCTNM Gross marginCTNM Operating incomeCTNM Operating cash flowCTNM Free cash flowCTNM Capital expendituresCTNM Return on equityCTNM Stock buybacksCTNM Dividends paidCTNM Total assetsCTNM Total liabilitiesCTNM Shareholders’ equityCTNM overview →